186 related articles for article (PubMed ID: 25267010)
1. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
2. Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F.
Lin AC; Liao CW; Lin SW; Huang CY; Liou CJ; Lai YS
Vet J; 2015 Aug; 205(2):254-62. PubMed ID: 25882637
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Chang CY; Chiou PP; Chen WJ; Li YH; Yiu JC; Cheng YH; Chen SD; Lin CT; Lai YS
Res Vet Sci; 2010 Apr; 88(2):285-93. PubMed ID: 19748110
[TBL] [Abstract][Full Text] [Related]
4. Bupivacaine induces apoptosis through caspase-dependent and -independent pathways in canine mammary tumor cells.
Chiu YS; Cheng YH; Lin SW; Chang TS; Liou CJ; Lai YS
Res Vet Sci; 2015 Jun; 100():232-8. PubMed ID: 25843897
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
6. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
[TBL] [Abstract][Full Text] [Related]
7. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.
Zhou C; Lin Z; Li X; Zhang D; Song P
Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
10. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
[TBL] [Abstract][Full Text] [Related]
11. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.
Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR
Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
13. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
14. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
[TBL] [Abstract][Full Text] [Related]
15. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line.
Nagamatsu K; Tsuchiya F; Oguma K; Maruyama H; Kano R; Hasegawa A
Res Vet Sci; 2008 Feb; 84(1):49-55. PubMed ID: 17537469
[TBL] [Abstract][Full Text] [Related]
16. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
17. Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.
Pawłowski KM; Mucha J; Majchrzak K; Motyl T; Król M
BMC Vet Res; 2013 Jun; 9():119. PubMed ID: 23773525
[TBL] [Abstract][Full Text] [Related]
18. Establishment of 5-Fluorouracil-resistant canine mammary tumor cell line.
Zhou B; Zhang D; Pei SM; Zhang H; Du HC; Jin YP; Lin DG
Pol J Vet Sci; 2017 Mar; 20(1):103-110. PubMed ID: 28525328
[TBL] [Abstract][Full Text] [Related]
19. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026.
Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y
Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
